Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

Why we do it

Focussing on innovation

- PMLiVE

LEO: Patients benefit from transparency

Paving the way for openness in pharma

- PMLiVE

The Truth about Doctors

‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and...

- PMLiVE

Thinking clearly and imagining better

Earning trust by temporarily ignoring business plans and goals

- PMLiVE

AbbVie and Roche plan Venclexta combo filings in leukaemia

MURANO trial shows the duo’s treatment extends PFS

- PMLiVE

Teva offloads women’s health unit in quickfire deals

The Israeli pharma group is also set to sell its oncology and pain business

Almirall looks to crowdsource new skin health treatments

Launches open innovation platform AlmirallShare

Four Health triumphs at PM Society Digital Awards

This year’s PM Society Digital Awards brought smiles all round Four Health and its clients, Johnson & Johnson and Novo Nordisk, with the agencies media and communications teams walking away...

Four Agency Worldwide

- PMLiVE

Lucid tackles Tough Mudder 2017

Last Saturday, twenty enthusiastic Lucidians took on the 2017 London South Tough Mudder Half challenge at the Holmbrush Estate in Surrey. Covering 5 miles and 13 imposing obstacles, the team...

Lucid Group Communications Limited

- PMLiVE

GSK closes in on EU approval for triple COPD therapy

CHMP backs its Telegy/Elebrato combination

Merck to co-lead new oncology big data alliance

Will work with Project Data Sphere to improve cancer care

- PMLiVE

CHMP backs maintenance therapy for Tesaro’s Zejula

Swiss biotech's PARP inhibitor recommended for approval in ovarian cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links